Lead Analyst
Vizient, Inc. | |
United States, Texas, Irving | |
290 East John Carpenter Freeway (Show on map) | |
Feb 06, 2026 | |
|
When you're the best, we're the best. We instill an environment where employees feel engaged, satisfied and able to contribute their unique skills and talents while living and working as their authentic selves. We provide extensive opportunities for personal and professional development, building both employee competence and organizational capability to fuel exceptional performance through an inclusive environment both now and in the future. Summary: Apexus serves as HRSA's Prime Vendor for the 340B Drug Pricing Program. We provide access to discounted medications, education and compliance needs and manufacturer refund services to more than 12,200 covered entities serving vulnerable populations. More information about the Prime Vendor Program (PVP) is available at www.340BPVP.com. In this role, you will support the 340B team responsible for optimizing 340B PVP purchasing and enhance covered entity savings. You will serve as a subject matter expert in 340B purchasing practices, PVP contract utilization, and the analysis of purchasing data. Your insights will drive value for PVP participants and inform internal strategies to develop education and contracts, bringing additional value to the program. Responsibilities:
Qualifications:
Estimated Hiring Range: At Vizient, we consider skills, experience, and organizational needs in our compensation approach. Geographic factors may adjust the range estimate and hires typically fall below the top range. Compensation decisions are tailored to individual circumstances. The current salary range for this role is $77,400.00 to $135,400.00.This position is also incentive eligible. Vizient has a comprehensive benefits plan! Please view our benefits here: http://www.vizientinc.com/about-us/careers Equal Opportunity Employer: Females/Minorities/Veterans/Individuals with Disabilities The Company is committed to equal employment opportunity to all employees and applicants without regard to race, religion, color, gender identity, ethnicity, age, national origin, sexual orientation, disability status, veteran status or any other category protected by applicable law. | |
Feb 06, 2026